Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.
Shardul Nautiyal, Mumbai Thursday, October 30, 2025, 08:00 Hrs [IST] ...
The partnership combines Körber's PAS-X MES platform with Pepperl+Fuchs' VisuNet interfaces for secure and regulatory ...
This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...
Ajinomoto Bio-Pharma Services and Olon S.p.A. have entered into a strategic partnership to deliver drug substance manufacturing services.
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an ...
Syngene International, a global CRDMO, is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru. With this new capability, Syngene will offer fully integrated, ...
VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a leader in innovative addiction ...
Syngene International plans to add bioconjugation suite for end-to-end ADC development: Our Bureau, Bengaluru Thursday, October 23, 2025, 15:15 Hrs [IST] Syngene International, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback